Mushroom compound may restore immune cells in cancer survivors

NCT ID NCT07258160

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a tablet called PRaG-1 (made from cordycepin, a mushroom extract) in people who had solid tumors and now have low CD8+ immune cells after finishing radiation or chemotherapy at least six months ago. About 127 participants will take the tablet for two weeks, and those whose immune cells improve will be randomly assigned to continue the drug or switch to a placebo for another two weeks. The goal is to see if the drug can safely raise CD8+ cell levels and keep them up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Second Affiliated Hospital of Soochow University

    RECRUITING

    Suzhou, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.